Emvision Medical Devices Ltd (EMV) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.301x

Based on the latest financial reports, Emvision Medical Devices Ltd (EMV) has a cash flow conversion efficiency ratio of -0.301x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-5.94 Million ≈ $-4.20 Million USD) by net assets (AU$19.74 Million ≈ $13.97 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See EMV net asset quality index to measure how much of total assets are equity-financed.

Emvision Medical Devices Ltd - Cash Flow Conversion Efficiency Trend (2018–2025)

This chart illustrates how Emvision Medical Devices Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check EMV capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.

Emvision Medical Devices Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Emvision Medical Devices Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Apex Biotechnology Corp
TW:1733
0.003x
Lotte Himart
KO:071840
-0.002x
Sound Financial Bancorp Inc
NASDAQ:SFBC
0.018x
Rafael Holdings, Inc.
NYSE:RFL
-0.090x
Lee Ku Ind
KO:025820
0.156x
Loop Telecommunication International Inc
TW:3025
0.069x
Balyo SA
PA:BALYO
-1.908x
Spheria Emerging Companies Ltd
AU:SEC
0.041x

Annual Cash Flow Conversion Efficiency for Emvision Medical Devices Ltd (2018–2025)

The table below shows the annual cash flow conversion efficiency of Emvision Medical Devices Ltd from 2018 to 2025. For the full company profile with market capitalisation and key ratios, see EMV stock market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 AU$9.28 Million
≈ $6.57 Million
AU$-7.84 Million
≈ $-5.54 Million
-0.844x -160.85%
2024-06-30 AU$18.52 Million
≈ $13.10 Million
AU$-5.99 Million
≈ $-4.24 Million
-0.324x -298.43%
2023-06-30 AU$5.12 Million
≈ $3.62 Million
AU$834.15K
≈ $590.22K
0.163x +130.53%
2022-06-30 AU$7.08 Million
≈ $5.01 Million
AU$-3.78 Million
≈ $-2.68 Million
-0.534x -19.47%
2021-06-30 AU$10.05 Million
≈ $7.11 Million
AU$-4.49 Million
≈ $-3.18 Million
-0.447x +24.14%
2020-06-30 AU$5.52 Million
≈ $3.91 Million
AU$-3.26 Million
≈ $-2.30 Million
-0.589x -22.46%
2019-06-30 AU$4.60 Million
≈ $3.26 Million
AU$-2.22 Million
≈ $-1.57 Million
-0.481x +9.42%
2018-06-30 AU$1.28 Million
≈ $905.05K
AU$-679.59K
≈ $-480.85K
-0.531x --

About Emvision Medical Devices Ltd

AU:EMV Australia Medical Devices
Market Cap
$100.28 Million
AU$141.73 Million AUD
Market Cap Rank
#19190 Global
#615 in Australia
Share Price
AU$1.53
Change (1 day)
-3.48%
52-Week Range
AU$1.48 - AU$2.37
All Time High
AU$4.13
About

EMVision Medical Devices Ltd engages in the research, development, and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, and other medical imaging needs in Australia. It offers non-invasive brain scanners, including emu Brain Scanner, a bedside device; and First Responder Brain Scanner, a device embedded in standard road and air ambulances to deliver pre-hospita… Read more